Phase II trial of everolimus monotherapy in the palliative treatment of patients with metastatic transitional cell carcinoma (TCC) after failure of platinum-based therapy: Activity and biomarkers.
2011 ◽
Vol 29
(15_suppl)
◽
pp. 4622-4622
Keyword(s):
Phase Ii
◽
2010 ◽
Vol 28
(15_suppl)
◽
pp. e15087-e15087
◽
2002 ◽
Vol 9
(3)
◽
pp. 162-166
◽